Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Adams

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Chemical Research in Toxicology|April 2, 2010
Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compoundsUmesh M Hanumegowda, Gottfried Wenke, Alicia Regueiro-Ren, et al.
The Cochrane Database of Systematic Reviews|September 24, 2025
Pharmacotherapy for mild hypertensionDominic Wang, James M Wright, Stephen P Adams, et al.
The Cochrane Database of Systematic Reviews|April 2, 2026
Pharmacotherapy for mild hypertensionDominic Wang, James M Wright, Stephen P Adams, et al.
Journal of Pharmacological and Toxicological Methods|January 16, 2007
Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissuesDieter M Drexler, Timothy J Garrett, Joseph L Cantone, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2001
The isolation and identification of a toxic impurity in XP315 drug substanceKenneth W Sigvardson, Stephen P Adams, T Bradford Barnes, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 19, 2008
Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the ratMark R Fielden, Alex Nie, Michael McMillian, et al.
Journal of Medicinal Chemistry|February 14, 2014
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvirMakonen Belema, Van N Nguyen, Carol Bachand, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Chemical Research in Toxicology|April 2, 2010
Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compoundsUmesh M Hanumegowda, Gottfried Wenke, Alicia Regueiro-Ren, et al.
The Cochrane Database of Systematic Reviews|September 24, 2025
Pharmacotherapy for mild hypertensionDominic Wang, James M Wright, Stephen P Adams, et al.
The Cochrane Database of Systematic Reviews|April 2, 2026
Pharmacotherapy for mild hypertensionDominic Wang, James M Wright, Stephen P Adams, et al.
Journal of Pharmacological and Toxicological Methods|January 16, 2007
Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissuesDieter M Drexler, Timothy J Garrett, Joseph L Cantone, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 30, 2001
The isolation and identification of a toxic impurity in XP315 drug substanceKenneth W Sigvardson, Stephen P Adams, T Bradford Barnes, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 19, 2008
Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the ratMark R Fielden, Alex Nie, Michael McMillian, et al.
Journal of Medicinal Chemistry|February 14, 2014
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvirMakonen Belema, Van N Nguyen, Carol Bachand, et al.
Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.
Pageof 2